{"name":"Eurofarma Laboratorios S.A.","slug":"eurofarma-laboratorios-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"cardiovascular","drugs":[{"name":"N1087","genericName":"N1087","slug":"n1087","indication":"Other","status":"phase_3"},{"name":"Alenia","genericName":"Alenia","slug":"alenia","indication":"Other","status":"phase_3"},{"name":"Cymbalta®","genericName":"Cymbalta®","slug":"cymbalta","indication":"Other","status":"marketed"},{"name":"Dextralgen","genericName":"Dextralgen","slug":"dextralgen","indication":"Other","status":"phase_3"},{"name":"Heptar","genericName":"Heptar","slug":"heptar","indication":"Other","status":"phase_3"},{"name":"Lactase Oral Tablets","genericName":"Lactase Oral Tablets","slug":"lactase-oral-tablets","indication":"Lactose intolerance management","status":"phase_3"},{"name":"Liquaemin","genericName":"Liquaemin","slug":"liquaemin","indication":"Other","status":"phase_3"},{"name":"Placebo of the experimental drug","genericName":"Placebo of the experimental drug","slug":"placebo-of-the-experimental-drug","indication":"Other","status":"phase_3"},{"name":"Tylex","genericName":"Tylex","slug":"tylex","indication":"Other","status":"phase_3"},{"name":"Vesomni®","genericName":"Vesomni®","slug":"vesomni","indication":"Benign prostatic hyperplasia with lower urinary tract symptoms (obstructive and storage symptoms)","status":"phase_3"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Comparator - Trimbow®","genericName":"Comparator - Trimbow®","slug":"comparator-trimbow","indication":"Chronic obstructive pulmonary disease (COPD) maintenance therapy","status":"phase_3"},{"name":"Budecort Aqua","genericName":"Budecort Aqua","slug":"budecort-aqua","indication":"Allergic rhinitis","status":"phase_3"},{"name":"Foraseq®","genericName":"Foraseq®","slug":"foraseq","indication":"Maintenance treatment of asthma","status":"phase_3"},{"name":"Formoterol/Fluticasone","genericName":"Formoterol/Fluticasone","slug":"formoterol-fluticasone","indication":"Asthma maintenance and reliever therapy","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"N0877","genericName":"N0877","slug":"n0877","indication":"Type 2 diabetes","status":"phase_3"},{"name":"N0728","genericName":"N0728","slug":"n0728","indication":"Type 2 diabetes","status":"phase_3"},{"name":"N0783","genericName":"N0783","slug":"n0783","indication":"Type 2 diabetes","status":"phase_3"},{"name":"Placebo Evogliptin","genericName":"Placebo Evogliptin","slug":"placebo-evogliptin","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Cosamin DS® (Nutramax)","genericName":"Cosamin DS® (Nutramax)","slug":"cosamin-ds-nutramax","indication":"Osteoarthritis pain and joint function support","status":"phase_3"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"Filgrastim (Eurofarma)","genericName":"Filgrastim (Eurofarma)","slug":"filgrastim-eurofarma","indication":"Chemotherapy-induced neutropenia","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Higroton® Laboratório Novartis","genericName":"Higroton® Laboratório Novartis","slug":"higroton-laborat-rio-novartis","indication":"Hypertension","status":"phase_3"}]},{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"rare","drugs":[{"name":"Minoxidil Topical Foam","genericName":"Minoxidil Topical Foam","slug":"minoxidil-topical-foam","indication":"Androgenetic alopecia (male pattern baldness)","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"metabolic","drugs":[{"name":"Nexium®","genericName":"Nexium®","slug":"nexium","indication":"Gastroesophageal reflux disease (GERD)","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"ophthalmology","drugs":[{"name":"Noex","genericName":"Noex","slug":"noex","indication":"Major depressive disorder","status":"phase_3"}]}],"pipeline":[{"name":"Comparator - Trimbow®","genericName":"Comparator - Trimbow®","slug":"comparator-trimbow","phase":"phase_3","mechanism":"Trimbow is a triple-combination inhaler that combines a long-acting beta-2 agonist, an inhaled corticosteroid, and a long-acting muscarinic antagonist to reduce airway inflammation and improve bronchial smooth muscle relaxation in chronic obstructive pulmonary disease.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"N0877","genericName":"N0877","slug":"n0877","phase":"phase_3","mechanism":"N0877 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"N1087","genericName":"N1087","slug":"n1087","phase":"phase_3","mechanism":"The mechanism of action for N1087 is currently unknown.","indications":[],"catalyst":""},{"name":"Alenia","genericName":"Alenia","slug":"alenia","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Budecort Aqua","genericName":"Budecort Aqua","slug":"budecort-aqua","phase":"phase_3","mechanism":"Budecort Aqua is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue.","indications":["Allergic rhinitis","Asthma (maintenance therapy)"],"catalyst":""},{"name":"Cosamin DS® (Nutramax)","genericName":"Cosamin DS® (Nutramax)","slug":"cosamin-ds-nutramax","phase":"phase_3","mechanism":"Cosamin DS is a dietary supplement containing glucosamine and chondroitin that may help maintain cartilage structure and reduce joint inflammation in osteoarthritis.","indications":["Osteoarthritis pain and joint function support"],"catalyst":""},{"name":"Cymbalta®","genericName":"Cymbalta®","slug":"cymbalta","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dextralgen","genericName":"Dextralgen","slug":"dextralgen","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Filgrastim (Eurofarma)","genericName":"Filgrastim (Eurofarma)","slug":"filgrastim-eurofarma","phase":"phase_3","mechanism":"Filgrastim is a granulocyte colony-stimulating factor (G-CSF) that stimulates the proliferation and differentiation of neutrophil progenitor cells in bone marrow.","indications":["Chemotherapy-induced neutropenia","Severe chronic neutropenia","Mobilization of peripheral blood progenitor cells for autologous transplantation"],"catalyst":""},{"name":"Foraseq®","genericName":"Foraseq®","slug":"foraseq","phase":"phase_3","mechanism":"Foraseq is a fixed-dose combination inhaled corticosteroid and long-acting beta-2 agonist for maintenance treatment of asthma and COPD.","indications":["Maintenance treatment of asthma","Maintenance treatment of COPD (Chronic Obstructive Pulmonary Disease)"],"catalyst":""},{"name":"Formoterol/Fluticasone","genericName":"Formoterol/Fluticasone","slug":"formoterol-fluticasone","phase":"phase_3","mechanism":"Formoterol is a long-acting beta-2 agonist that relaxes airway smooth muscle, while fluticasone is a corticosteroid that reduces airway inflammation.","indications":["Asthma maintenance and reliever therapy","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Heptar","genericName":"Heptar","slug":"heptar","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Higroton® Laboratório Novartis","genericName":"Higroton® Laboratório Novartis","slug":"higroton-laborat-rio-novartis","phase":"phase_3","mechanism":"Higroton (chlorthalidone) is a thiazide-like diuretic that inhibits sodium and chloride reabsorption in the distal convoluted tubule, promoting urinary excretion and reducing blood volume and blood pressure.","indications":["Hypertension","Edema associated with congestive heart failure or renal disease"],"catalyst":""},{"name":"Lactase Oral Tablets","genericName":"Lactase Oral Tablets","slug":"lactase-oral-tablets","phase":"phase_3","mechanism":"Lactase is an enzyme that breaks down lactose (milk sugar) into glucose and galactose for absorption in the small intestine.","indications":["Lactose intolerance management"],"catalyst":""},{"name":"Liquaemin","genericName":"Liquaemin","slug":"liquaemin","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Minoxidil Topical Foam","genericName":"Minoxidil Topical Foam","slug":"minoxidil-topical-foam","phase":"phase_3","mechanism":"Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle.","indications":["Androgenetic alopecia (male pattern baldness)","Hair loss in women"],"catalyst":""},{"name":"N0728","genericName":"N0728","slug":"n0728","phase":"phase_3","mechanism":"N0728 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"N0783","genericName":"N0783","slug":"n0783","phase":"phase_3","mechanism":"N0783 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Nexium®","genericName":"Nexium®","slug":"nexium","phase":"marketed","mechanism":"Nexium inhibits gastric acid secretion by blocking proton pumps in the stomach lining.","indications":["Gastroesophageal reflux disease (GERD)","Peptic ulcer disease","Zollinger-Ellison syndrome","Prevention of NSAID-induced ulcers"],"catalyst":""},{"name":"Noex","genericName":"Noex","slug":"noex","phase":"phase_3","mechanism":"Noex is a medication that works by inhibiting the enzyme responsible for the breakdown of a certain neurotransmitter.","indications":["Major depressive disorder","Obsessive-compulsive disorder"],"catalyst":""},{"name":"Placebo Evogliptin","genericName":"Placebo Evogliptin","slug":"placebo-evogliptin","phase":"phase_3","mechanism":"Evogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Placebo of the experimental drug","genericName":"Placebo of the experimental drug","slug":"placebo-of-the-experimental-drug","phase":"phase_3","mechanism":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","indications":[],"catalyst":""},{"name":"Tylex","genericName":"Tylex","slug":"tylex","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Vesomni®","genericName":"Vesomni®","slug":"vesomni","phase":"phase_3","mechanism":"Vesomni is a combination of silodosin (alpha-1A adrenergic antagonist) and mirabegron (beta-3 adrenergic agonist) that addresses both obstructive and storage symptoms of benign prostatic hyperplasia.","indications":["Benign prostatic hyperplasia with lower urinary tract symptoms (obstructive and storage symptoms)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxObHc0Tjk4Vm93TE0zWkYySUhNZ2t5SXUtNXBHMnh0MmUySDRPbFVqRENxQlFsTG9BUmNLTXlXT0tYX0Vic082VHRCb29xcThpbVdDQUgydDczN2tvazM5eHdaR196clJLcmR5OTI3X0NMdnRIVU4yTmE5QmpNcDcxYTBycW5lcWhqYXQ4bExQeU1UT0QzT1NESVRmYlBSbVBETXpiRlhHTDZ6RW55Rm9oVU5TM013a25WZlJBMXdza1RuMUdUdW9xck9vY29GS1ZUVjRGa0ozenR4ZDNGN2d4QlNpT2NBS0xQVU5hRllR?oc=5","date":"2025-10-20","type":"pipeline","source":"PR Newswire","summary":"SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform - PR Newswire","headline":"SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE92bXN1NDVORmVWZUZjSVU0cE9uTlZmaVpPNUJwU3h3Vjh1V056OVVSS0F3alBKYXI1ZThydXd5NE93WXptVklvclJrT3FsZVd0QlpVRG41LVV6X3F6LXBqdEYyT0tnNE1HbmE2RGFR?oc=5","date":"2025-01-15","type":"pipeline","source":"KED Global","summary":"SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US - KED Global","headline":"SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNeHVuX2dGUkN3Zmx1UkhIQm9BbHBxQzU1SkdjeE40RFptVXp5a04xcEFXZ2xsRDNoWl9TQUtWWm1KTVJiV2E3MFBRdms2SUhPdDU4dDM4MXpWLTlCRTYzQTB6WnFCQjN1WUdtNFhTdXBLMzJmYWVidndPZWUyNVQ1b20tdGd3X240cmMyNVdaenJlUQ?oc=5","date":"2023-12-12","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Genfar: Eurofarma's new generic brand in Latin America - Generics and Biosimilars Initiative","headline":"Genfar: Eurofarma's new generic brand in Latin America","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE85UHNjd1F2V1pkWWNwLU9BbElEcGhYeTQzb19hTTBtT2k0bXRWM1Z5Z1FwUkh3VTVKcGFqcGU1ekRzeDZUX1o0UjRpZXZucy1lOXFTZEp4WDlCdUR5RWk5d2RvMC1GemxFbDM0Z29R?oc=5","date":"2023-06-15","type":"pipeline","source":"KED Global","summary":"SK Biopharm’s Cenobamate gets nod in Canada, to boost US sales - KED Global","headline":"SK Biopharm’s Cenobamate gets nod in Canada, to boost US sales","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5CX0Zrb3JaaGY1cE1GWkNzSTJoVl85U3U4QldMUXdFTEN2QWs2amRkTWxQREZiSzlhSzZ5eHRBNkUwY0Jab3ZIQTRJZlc0dk8zVk8td2lqUTA5akJKcjRQMGtsalJrU0MxRHNwY0lR0gFyQVVfeXFMUFBxSFNGQkR5cGg1NmhocU9CbE5fY3VVR3J3MkljRXhjMElla29ITUJhQUxMNjl4aUlMcmRXMEtIdXRHbExTRENxWTlGaGxyU3dLcE9JUGZLa3JSSVZYVFZ3NzBHUHJLSDJOcWVJOEl4dlBn?oc=5","date":"2022-07-14","type":"deal","source":"koreabiomed.com","summary":"SK Biopharmaceuticals signs $62 million deal to export anti-seizure drug to Latin America - koreabiomed.com","headline":"SK Biopharmaceuticals signs $62 million deal to export anti-seizure drug to Latin America","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE1Tdk9ucF9pM3BlOTJfdmMtZUpTaWxRM3BiSGpyUGRrNERQNkhmOUcxRVJIQy1lUS1HNnRoZlZid1VRb2FoTDlBYks3bndxNEozbDBhUldWcWlCWER4UjdGYQ?oc=5","date":"2022-05-11","type":"deal","source":"复宏汉霖","summary":"Henlius and Eurofarma Entered into a License Agreement for Henlius' 3 Products in Latin America - 复宏汉霖","headline":"Henlius and Eurofarma Entered into a License Agreement for Henlius' 3 Products in Latin America - 复宏汉霖","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxPeC1yS3JUdHdZSmgyM2lFM2ZhaTNseHhlQjhHNkFCcmQ1SklfYUZ0VGtlQVBzNlR5T2NnbXJJSjY4M0ROOXlTTUFlWG1SNl8yVmVEZFk2aEtLRTZ6RlJFZE1zQjI0U210cFVGdWNsNGxEZW1lZ05DNFM0MzhvckRNZlgyM2d1Z1BWcWZYbkhTbmp6cXFpb3ZRRFdqNl9oV3pMYS1HLWQtelAxQ2tIV3gtTzJGZnVDdHFFQS15R2pjQnFGYXFCZUl1SFYwU3FIRjVzS0xQM1FjMmJza0tqQ0tsSUN1SjVsN3E4NU5USklJbk14d2JSMDBVbE9Yd1ZGZ2tMcHFLTzB2cWVYSDlLeGNQN21QbmFtMWZNemtGRlhmZzJKQQ?oc=5","date":"2012-02-15","type":"patent","source":"Via Ritzau","summary":"Merck Establishes Joint Venture with Supera Farma to Commercialize Innovative Pharmaceutical Products and Branded Generics in Brazil - Via Ritzau","headline":"Merck Establishes Joint Venture with Supera Farma to Commercialize Innovative Pharmaceutical Products and Branded Generi","sentiment":"neutral"}],"patents":[],"drugCount":24,"phaseCounts":{"phase_3":22,"marketed":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}